T11	Drug 750 797	ectopic expression of miR‐144‐5p and miR‐144‐3p
T12	Disease 847 851	LUSQ
T13	Disease 863 869	cancer
T14	Disease 918 922	LUSQ
T17	Biomarker 1198 1221	high expression of NCS1
T18	Disease 1282 1286	LUSQ
T19	Biomarker 1378 1393	NCS1 expression
T2	Disease 59 102	advanced‐stage lung squamous cell carcinoma
#7	AnnotatorNotes T2	DOID:3907
T20	Disease 1461 1465	LUSQ
T21	Biomarker 1476 1498	Overexpression of NCS1
T22	Disease 1515 1519	LUSQ
T23	Disease 1605 1609	LUSQ
T24	Disease 1775 1779	LUSQ
T26	Chemical 1815 1823	dopamine
T27	Disease 1895 1914	lung adenocarcinoma
#13	AnnotatorNotes T27	DOID:3910
T28	Disease 1920 1948	lung squamous cell carcinoma
#14	AnnotatorNotes T28	DOID:3907
T30	Chemical 1970 1977	alanine
T31	Chemical 2039 2046	calcium
T32	Disease 2062 2088	non‐small cell lung cancer
#18	AnnotatorNotes T32	DOID:3908
T33	Disease 2151 2171	renal cell carcinoma
#19	AnnotatorNotes T33	DOID:4450
T4	Disease 104 108	LUSQ
T5	Disease 292 296	LUSQ
T7	Disease 486 492	cancer
#24	AnnotatorNotes T7	DOID:162
T8	Biomarker 516 544	low expression of miR‐144‐5p
T9	Disease 603 607	LUSQ
T1	RNA-Noncoding 382 389	miR‐144
#1	AnnotatorNotes T1	HGNC:31531
T3	RNA-Noncoding 391 401	miR‐144‐5p
#3	AnnotatorNotes T3	HGNC:31531
#5	AnnotatorNotes T4	DOID:3907
T37	RNA-Noncoding 425 435	miR‐144‐3p
T38	Biomarker 382 482	miR‐144 (miR‐144‐5p, the passenger strand; miR‐144‐3p, the guide strand) showed decreased expression
R1	Association Arg1:T38 Arg2:T7	
T6	RNA-Noncoding 534 544	miR‐144‐5p
R2	Prognostic-Poor Arg1:T8 Arg2:T9	
T10	RNA-Noncoding 772 782	miR‐144‐5p
T39	RNA-Noncoding 787 797	miR‐144‐3p
#2	AnnotatorNotes T11	not found
R3	Response Arg1:T11 Arg2:T12	
T40	RNA-Noncoding 1019 1029	miR‐144‐5p
T41	RNA-Noncoding 1034 1044	miR‐144‐3p
T15	Gene-Protein 1104 1111	SLC44A5
#4	AnnotatorNotes T15	HGNC:28524
T42	Gene-Protein 1125 1129	NCS1
#6	AnnotatorNotes T42	HGNC:3953
T43	Gene-Protein 1113 1119	MARCKS
#8	AnnotatorNotes T43	HGNC:6759
T44	RNA-Noncoding 1174 1181	miR‐144
T16	Gene-Protein 1217 1221	NCS1
T45	Gene-Protein 1378 1382	NCS1
T46	Gene-Protein 1494 1498	NCS1
T47	Gene-Protein 2025 2029	NCS1
R4	Prognostic-Poor Arg1:T17 Arg2:T18	
R5	Association Arg1:T19 Arg2:T20	
T48	Collection 1515 1609	LUSQ clinical specimens, and its aberrant expression enhanced malignant transformation of LUSQ
R6	Association Arg1:T21 Arg2:T48	
T49	Disease 2056 2061	NSCLC
#9	AnnotatorNotes T49	DOID:3908
T25	Gene-Protein 1949 1955	MARCKS
T34	Gene-Protein 1956 2009	myristoylated alanine rich protein kinase C substrate
T29	Gene-Protein 2030 2055	neuronal calcium sensor 1
T50	Disease 2147 2150	RCC
#10	AnnotatorNotes T50	DOID:4450
T51	Gene-Protein 2235 2242	SLC44A5
T52	Gene-Protein 2243 2276	solute carrier family 44 member 5
#11	AnnotatorNotes T37	HGNC:31531
T35	Gene-Protein 1795 1799	Ago2
#12	AnnotatorNotes T35	HGNC:3263
T54	Gene-Protein 1800 1810	Argonaute2
#15	AnnotatorNotes T54	HGNC:3263
T55	Gene-Protein 1811 1814	D2R
#16	AnnotatorNotes T55	HGNC:3023
T56	Gene-Protein 1815 1835	dopamine D2 receptor
#17	AnnotatorNotes T56	HGNC:3023
T57	Disease 1890 1894	LUAD
T58	Disease 1915 1919	LUSQ
#20	AnnotatorNotes T57	DOID:3910
